fluphenazine depot has been researched along with Movement Disorders in 4 studies
fluphenazine decanoate : The prodrug of fluphenazine, an antipsychotic drug used for the symptomatic management of psychosis in patients with schizophrenia.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Long-acting injectable risperidone was assessed in schizophrenia patients who were symptomatically stable on conventional depot antipsychotics and who were then switched to long-acting risperidone." | 5.11 | Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics. ( Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M, 2004) |
| "Schizophrenia is thought to be the psychiatric diagnosis the most frequently associated with TD." | 1.39 | [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics]. ( Bellaaj, R; Bouguerra, C; Gallali, S; Mehdi, F; Oumaya, A; Sejil, I, 2013) |
| " The mean dosage of the drug was 25-50 mg per 3-4 weeks." | 1.27 | [Long-term moditen-depot treatment of schizophrenic patients at a psychoneurology dispensary]. ( Abramova, LI; Gushanskiĭ, EL, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sejil, I | 1 |
| Oumaya, A | 1 |
| Bouguerra, C | 1 |
| Mehdi, F | 1 |
| Bellaaj, R | 1 |
| Gallali, S | 1 |
| Turner, M | 1 |
| Eerdekens, E | 1 |
| Jacko, M | 1 |
| Eerdekens, M | 1 |
| Marder, SR | 1 |
| Van Putten, T | 1 |
| Mintz, J | 1 |
| McKenzie, J | 1 |
| Lebell, M | 1 |
| Faltico, G | 1 |
| May, PR | 1 |
| Abramova, LI | 1 |
| Gushanskiĭ, EL | 1 |
2 trials available for fluphenazine depot and Movement Disorders
| Article | Year |
|---|---|
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, | 2004 |
Costs and benefits of two doses of fluphenazine.
Topics: Adult; Clinical Trials as Topic; Cost-Benefit Analysis; Double-Blind Method; Drug Administration Sch | 1984 |
2 other studies available for fluphenazine depot and Movement Disorders
| Article | Year |
|---|---|
[Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
Topics: Adult; Antipsychotic Agents; Cross-Sectional Studies; Delayed-Action Preparations; Dose-Response Rel | 2013 |
[Long-term moditen-depot treatment of schizophrenic patients at a psychoneurology dispensary].
Topics: Adult; Affective Symptoms; Ambulatory Care; Antidepressive Agents; Drug Therapy, Combination; Female | 1986 |